Autoimmunity results from a breakdown of immune tolerance that allows the immune system to attack self-antigens. Tolerance mechanisms normally distinguish self from non-self and prevent autoreactive immune cells from developing or differentiating. Failure of these tolerance mechanisms can lead to autoimmune diseases. Autoimmune disorders range from organ-specific diseases targeting a single tissue to systemic diseases affecting multiple tissues. Treatment of autoimmune diseases includes medications like NSAIDs, corticosteroids, DMARDs, and biologics, as well as procedures like plasmapheresis and surgery.
Autoimmunity results from a breakdown of immune tolerance that allows the immune system to attack self-antigens. Tolerance mechanisms normally distinguish self from non-self and prevent autoreactive immune cells from developing or differentiating. Failure of these tolerance mechanisms can lead to autoimmune diseases. Autoimmune disorders range from organ-specific diseases targeting a single tissue to systemic diseases affecting multiple tissues. Treatment of autoimmune diseases includes medications like NSAIDs, corticosteroids, DMARDs, and biologics, as well as procedures like plasmapheresis and surgery.
Autoimmunity results from a breakdown of immune tolerance that allows the immune system to attack self-antigens. Tolerance mechanisms normally distinguish self from non-self and prevent autoreactive immune cells from developing or differentiating. Failure of these tolerance mechanisms can lead to autoimmune diseases. Autoimmune disorders range from organ-specific diseases targeting a single tissue to systemic diseases affecting multiple tissues. Treatment of autoimmune diseases includes medications like NSAIDs, corticosteroids, DMARDs, and biologics, as well as procedures like plasmapheresis and surgery.
Autoimmunity is an adaptive immune response to self-antigens leading to
production of autoantibodies and self-reactive T cells attacking the self-molecule due to a breakdown of immune tolerance to auto-reactive immune cells which may causes autoimmune diseases. Tolerance mechanisms have evolved to distinguish self and non-self, and block the development of growth, or differentiation of autoreactive lymphocytes. Immunological tolerance to different autoantigens may be induced when immature lymphocytes recognize these antigens in the generative (central) lymphoid organs, a process called central tolerance, or when mature lymphocytes encounter autoantigens in peripheral (secondary) lymphoid organs or peripheral tissues, called peripheral tolerance. Tolerance induction and maintenance mechanisms vary between the B and T cells and the central and peripheral lymphoid. The failure of that auto-tolerance may result in autoimmune disease. Factors that evolve into autoimmune disease include genetic predisposition, structural modification of tissue protein, cross reactivity and breakdown in the immune network. Autoimmune disorders are a spectrum of diseases ranging from organ-specific diseases in which antibodies and T cells respond to self-antigens found in a single specific tissue (such autoimmune thyroid diseases: Grave’s disease, myxedema and Hashimoto's disease) to systemic diseases characterized by reactivity to a common antigen or antigens distributed across the body's various tissues (such that occurs in SLE and rheumatoid arthritis). In Rheumatoid arthritis, the pathogenesis of such disease is complex with multiple genetic, environmental, immunologic, and other factors contributing to the development and expression of disease. Diagnosis of Rheumatoid arthritis disease can be done by blood test, imaging tests, ELISA Test and Multiplex cytofluorimetric test which is more sensitive and specific. In Graves' disease, there is a generalized over-activity of the entire thyroid gland caused by auto-antibodies to TSHR. B-cells and T-cells play an important role in such cases. Diagnosis of Grave’s disease is done by Physical examinations to the eye and thyroid gland, blood tests, radioactive iodine uptake, Ultrasound waves and Imaging tests.
In Systemic lupus erythematosus, it is characterized by the production of
autoreactive antibodies and cytokines. It may be due to genetic or environmental causes. It ranges from relatively benign disease to rapidly progressive and even fatal disease. IL-1, Gelatinase B or MMP-9 and antibody play a significant role in such disease.
Treatment of autoimmune disease includes NSAIDs, Corticosteroids, Disease-
modifying anti-rheumatic drugs (DMARDs), Biologics (A relatively new class of DMARDs made of synthetic proteins), Intravenous Immunoglobulin, Plasmapheresis (a process that clears the plasma from autoantibodies) and Surgery to cope with certain autoimmune disease complications.